Tags: Drug.

Quisinostat (USAN; development code JNJ-26481585) is an experimental drug candidate for the treatment of cancer. It is a second generation histone deacetylase inhibitor with antineoplastic activity.

Quisinostat.svg
ATC prefix
None
IUPAC name
N-Hydroxy-2-[4-([(1-methyl-1H-indol-3-yl)methyl]aminomethyl)-1-piperidinyl]-5-pyrimidinecarboxamide
PubChem
11538455

Loading...

This page contains content from the copyrighted Wikipedia article "Quisinostat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.